April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Predictors of Success of Selective Laser Trabeculoplasty
Author Affiliations & Notes
  • S. Jea
    Ophthalmology, Massachusetts Eye and Ear Infirmary/Harvard Medical School, Boston, Massachusetts
  • L. R. Pasquale
    Ophthalmology, Massachusetts Eye and Ear Infirmary/Harvard Medical School, Boston, Massachusetts
  • C. L. Grosskreutz
    Ophthalmology, Massachusetts Eye and Ear Infirmary/Harvard Medical School, Boston, Massachusetts
  • D. J. Rhee
    Ophthalmology, Massachusetts Eye and Ear Infirmary/Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  S. Jea, None; L.R. Pasquale, None; C.L. Grosskreutz, None; D.J. Rhee, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4420. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Jea, L. R. Pasquale, C. L. Grosskreutz, D. J. Rhee; Predictors of Success of Selective Laser Trabeculoplasty. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4420.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the predictive value of selective laser trabeculoplasty (SLT) results in one eye on the contralateral eye.

Methods: : Retrospective chart review of all cases performed by three surgeons between 2002 and 2008. Inclusion criteria were open-angle glaucoma, age 18 years or older, uncontrolled with maximum tolerable medical therapy, treated with SLT in both eyes, and follow-up for more than 6 months. Success was defined as a decrease in IOP of at least 3 mmHg maintaining through the last follow-up without use of any additional medication or laser or incisional surgical intervention.

Results: : 178 eyes of 89 patients met our inclusion criteria. 67 patients (75.3%) showed the same result, success or failure, in the contralateral eye. Multivariate conditional logistic regression analysis of patients who had a differing results between the two eyes (n=22) showed that pretreatment medication number (p = .030; OR 0.053; 95% C.I. 0.004-0.756), and SLT energy (p = .038; OR <0.001; 95% C.I. 0.000-0.475) were associated with a greater chance of success. In patients whose first eye failed, multivariate Cox proportional hazard analysis comparing those who were successful (n=19) versus failed eyes (n=46) in the second eye showed that a higher baseline IOP (p = .026; hazard ratio(HR) 0.894; 95% C.I. 0.810-0.986) was associated with a greater chance of success.

Conclusions: : The result of the first eye is predictive of the result in the contralateral eye. If there is a poor response to SLT in one eye, greater baseline antiglaucoma medications, higher baseline IOP, higher laser power were associated with a greater chance of success. Higher treatment energy may be helpful to obtain better outcomes when applying a SLT to the contralateral eye.

Keywords: intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×